TITLE: Relating to discussing with a patient the risks of certain controlled substance prescriptions.

SUMMARY: Relating to discussing with a patient the risks of certain controlled substance prescriptions.

FULL TEXT:
AN ACT relating to discussing with a patient the risks of certain controlled substance prescriptions. BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: SECTION 1. Section 481.0764, Health and Safety Code, is amended by adding Subsections (f) and (g) to read as follows: (f) A prescriber, other than a veterinarian, on issuance of the initial prescription for a Schedule II controlled substance or an opioid, shall discuss with the patient and, if the patient is a minor, the patient's parent, conservator, or guardian, or other person authorized to consent to the minor's medical treatment: (1) the risk of addiction associated with the drug prescribed, including any risk of developing a physical or psychological dependence on the drug; (2) the risk of overdose associated with the drug prescribed; and (3) the danger of taking the drug with benzodiazepines, alcohol, or other central nervous system depressants. (g) A prescriber who discusses the risks of a controlled substance prescription under Subsection (f) shall note the discussion in the patient's medical record. SECTION 2. The change in law made by this Act applies only to a prescription issued on or after the effective date of this Act. A prescription issued before the effective date of this Act is governed by the law in effect on the date the prescription is issued, and the former law is continued in effect for that purpose. SECTION 3. This Act takes effect September 1, 2019.